Sintilimab Combined With Chemotherapy Induction Therapy Followed by CCRT vs. CCRT for Esophageal Cancer: A Randomized Controlled Phase Ⅲ Clinical Study
Clinical trial NCT07306663 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07306663
- Sponsor
- Jiangsu Cancer Institute & Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-01
- Primary completion
- 2028-06-01
- Enrollment
- 242
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.